Labcorp Holdings (LH) return on equity (ROE)

Return on equity · fiscal 2025
10.2%

Labcorp Holdings (LH) earned a return on equity of 10.2% in fiscal 2025 (the year ended December 31, 2025). That is 0.9 percentage points higher than the 9.3% of fiscal 2024. Figures as of 17 Nov 2026, 21:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
10.2%
Change on fiscal 2024
+0.9 pts
Highest on record
27.6%fiscal 2007
Lowest on record
5.3%fiscal 2023
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Labcorp Holdings return on equity (ROE), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was 27.6% in fiscal 2007 and the lowest 5.3% in fiscal 2023. The fiscal 2025 figure is higher than in 17% of the 18 earlier fiscal years on record, whose median is 17.3%.

History · 19 fiscal years

Return on equity by fiscal year

Labcorp Holdings return on equity (ROE), year by year

Labcorp Holdings (LH) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202510.2% 0.9 pts up
20249.3% 4.0 pts up
20235.3% 7.4 pts down
202212.7% 10.5 pts down
202123.1% 6.7 pts up
202016.5% 5.7 pts up
201910.8% 1.8 pts down
201812.5% 5.5 pts down
201718.0% 5.1 pts up
201612.9% 4.0 pts up
20158.8% 9.3 pts down
201418.1% 4.9 pts down
201323.0% 11.2 pts up
201211.8% 9.0 pts down
201120.8% 1.9 pts down
201022.6% 3.2 pts down
200925.8% 1.7 pts down
200827.5% 0.1 pts down
200727.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Labcorp Holdings and comparable companies
CompanyReturn on equityFiscal year
ResMed RMD23.1%2026
Zoetis ZTS80.2%2025
Labcorp Holdings LH10.2%2025
DexCom DXCM30.5%2025
Koninklijke Philips PHG8.2%2025
Roivant Sciences ROIV-6.6%2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LH

Labcorp Holdings, figure by figure

Labcorp Holdings (LH) overview: price, valuation and scorecardAll health care companies by market value

Labcorp Holdings return on equity (ROE): questions and answers

What is Labcorp Holdings's return on equity?

Labcorp Holdings (LH) earned a return on equity of 10.2% in fiscal 2025 (the year ended December 31, 2025). That is 0.9 percentage points higher than the 9.3% of fiscal 2024.

Is Labcorp Holdings's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 17% of the 18 earlier fiscal years on record, whose median is 17.3%.

What are the highest and lowest return on equity figures on record for Labcorp Holdings?

Across the 19 fiscal years on record (2007–2025), the highest was 27.6% in fiscal 2007 and the lowest 5.3% in fiscal 2023.

How is Labcorp Holdings's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Labcorp Holdings (LH) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/LH/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.